1/21/2010 | DD | deCODE genetics completes sale, changes name to DGI Resolution
|
1/14/2010 | DD | deCODE genetics gets court OK to sell assets to Saga Investments
|
1/12/2010 | DD | deCODE genetics cancels auction, receives no qualified competing bids
|
12/9/2009 | DD | deCODE's bid procedures for sale of its subsidiary approved by court
|
12/8/2009 | DD | deCODE creditors object to DIP loan linked to speedy sale process
|
12/1/2009 | DD | deCODE unsecured creditors committee appointed by U.S. Trustee
|
11/19/2009 | DD | deCODE genetics requests court approval of asset sale procedures
|
11/18/2009 | DD | deCODE interim DIP financing OK'd, bid procedures motion withdrawn
|
11/17/2009 | CV | Market Commentary: Kilroy dips below par on debut, TRW trades at 101; deCODE off on bankruptcy; DryShips on tap
|
11/17/2009 | CVDDSS | deCODE genetics files bankruptcy, inks agreement to sell assets
|
10/14/2009 | CVDD | deCODE to skip Oct. 15 interest payment on 3.5% convertible notes
|
5/19/2009 | CVDD | deCODE pays interest on 3.5% senior convertibles within grace period
|
5/12/2009 | CVDDSS | deCODE still working to address need for liquidity beyond second quarter
|
4/15/2009 | CVDD | deCODE Genetics delays convertibles payment, to consider alternatives
|
3/31/2009 | CVDDSS | deCODE needs cash to continue beyond second quarter
|
11/6/2008 | CVDD | deCODE reviewing ways to make interest payment, needs more funding to continue operations past 2008
|
10/15/2008 | CVDD | deCODE genetics to use grace period on convertible interest payment to review alternatives
|
11/17/2006 | CV | deCODE underwriters exercise greenshoe, upping convertibles to $80 million
|
11/14/2006 | BTCV | New Issue: deCODE prices $65 million five-year convertibles at 3.5%, up 176.7%; offered at 70
|
11/14/2006 | CV | Market Commentary: Earthlink, EMC, deCODE rise; Bunge climbs on new talk; Health Care, China Medical face tough borrow
|
11/13/2006 | CV | Market Commentary: EMC, Earthlink gain in gray; UAL cracks on LBO rumors; Bunge, Health Care REIT lead issuance surge
|
11/13/2006 | BTCV | deCODE to offer five-year convertibles, priced at 3.5%, up 176.7%; terms will echo older note series
|
11/9/2006 | BT | deCODE planning to begin 2007 with two years' cash on hand
|
10/6/2006 | BT | Jefferies puts deCODE at buy
|
9/26/2006 | BT | deCODE files suit against five former employees
|
8/14/2006 | BT | deCODE enrolling patients in phase 1 study of DG051 for prevention of heart attack
|
8/10/2006 | BT | deCODE at buy by Jefferies
|
7/18/2006 | CV | Market Commentary: Avnet improves on Lehman recommendation; Sanmina-SCI unmoved by warning; New River plans deal
|
7/17/2006 | PP | Market Commentary: BPK pockets $4.5 million from note offering; TrueYou settles $5.2 million private placement
|
7/14/2006 | BT | Market Commentary: deCODE secures $30 million from stock sale; Micrus stock edges up following public stock offering
|
7/14/2006 | CV | Market Commentary: Ford slides as story sputters; GM weaker; deCODE Genetics widens; Teva steady despite loss to Forest
|
7/14/2006 | PP | Market Commentary: Lorus secures C$10.36 million from PIPE; deCODE gears up to wrap $30 million direct stock deal
|
7/14/2006 | BTPP | New Issue: deCODE genetics secures $30 million from stock sale
|
6/29/2006 | BT | deCODE genetics submits IND for DG051 for prevention of heart attack
|
6/27/2006 | BT | deCODE says it will spend majority of research and development funding on DG031
|
6/26/2006 | BT | deCODE says phase 2 trial of CEP-1347 in asthma yields positive results
|
6/22/2006 | BT | deCODE begins enrollment in phase 2a study of DG041 in peripheral artery disease
|
5/17/2006 | BT | deCODE starts phase 3 trial for DG031 to prevent heart attack
|
5/15/2006 | BT | deCODE, Illumina to develop, commercialize DNA-based diagnostics
|
5/3/2006 | BT | deCODE to start phase 3 trial of DG031 to prevent heart attack
|
5/2/2006 | BT | Market Commentary: Vical top pick in bird flu flock; Noven sinks on profit taking; NitroMed dives, Myriad higher
|
2/21/2006 | BT | deCODE peripheral artery disease drug DG041 shows promise in phase 1 study
|
1/18/2006 | BT | deCODE expands cancer program, acquires Icelandic cancer research group
|
1/17/2006 | BT | Market Commentary: Arena gains in face of follow-on deal; deCODE spikes on diabetes discovery; Acadia, Sepracor firm
|
1/17/2006 | BT | deCODE finds gene variant that increases risk for diabetes
|
12/5/2005 | BTCV | deCode genetics files $100 million shelf
|
11/10/2005 | BT | deCODE finds gene variant that increases risk for heart attack
|
8/3/2005 | BT | deCode price target upped by Jefferies
|
5/18/2005 | CV | Market Commentary: Xoma, deCode, Cephalon buyers seen; XM, Sirius at odds in race; Beverly auction in second round
|
9/17/2004 | CV | Market Commentary: Sepracor issue straddles par; Vitesse goes to 103; EDS firm despite warning; biotechs rally
|
4/26/2004 | CV | Market Commentary: OSI Pharma skyrockets amid buying frenzy as stock shoots up 139%; 4 new deals emerge
|
4/14/2004 | CV | Decode greenshoe exercised, raising convertibles to $150 million
|
4/7/2004 | CV | Market Commentary: Allied Waste thrashed about on tighter talk but firms back up to 101 in gray; Decode at 101.25
|
4/7/2004 | CV | New Issue: Decode Genetics upsized $125 million convertible yields 3.5%, up 35%
|
4/6/2004 | CV | Market Commentary: Cummins, Navistar rev up; RF Micro falls on Nokia warning; Allied Waste airs deal plans
|
4/5/2004 | CV | Decode Genetics $100 million convertible talked at 3.5-4.0%, up 30-35%
|
4/5/2004 | CV | Market Commentary: Financial Federal bid 100.5 in gray market; Decode Genetics emerges; gaming paper on fire
|
5/3/2002 | CV | Iceland to guarantee up to $200 million deCODE convertibles
|